What question did this study set out to answer?

The aim is to examine the relationship between serum IL-17, Treg cell levels, and the effectiveness of excimer light therapy in progressive vitiligo.

April 16, 2026

Correlation between serum IL-17 and peripheral blood Treg cells and efficacy of 308 nm excimer light therapy in progressive vitiligo

Puntos clave

The aim is to examine the relationship between serum IL-17, Treg cell levels, and the effectiveness of excimer light therapy in progressive vitiligo.
Measured serum IL-17 and Treg cell levels before and after treatment
Assessed treatment outcomes using VASI scores
Compared biomarker profiles between progressive and stable vitiligo
Analyzed the correlation between biomarkers and therapy efficacy
Baseline IL-17 and Treg cell levels correlate with treatment outcomes
Distinct biomarker profiles were observed between progressive and stable vitiligo
Combining baseline markers enhances the evaluation of potential treatment response

Resumen

Baseline and post-treatment serum IL-17 and Treg cell levels, along with VASI scores, correlate with 308 nm excimer light therapy outcomes in progressive vitiligo. These baseline biomarkers, particularly IL-17 and Treg cells, are associated with treatment response. Distinct biomarker profiles exist between progressive and stable vitiligo. Combined baseline marker testing improves the evaluation of treatment potential.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Wang et al. (Tue,) studied this question.

synapsesocial.com/papers/69e07dad2f7e8953b7cbe9af https://doi.org/https://doi.org/10.1080/15569527.2026.2646449

Preguntar a la IA

Me gusta

Guardar